What Are the Challenges in Balancing IP and Public Health?
One of the main challenges is ensuring that IP rights do not hinder access to essential medicines. High costs of patented cancer drugs can put them out of reach for many patients, especially in low- and middle-income countries. Efforts to balance IP and public health include compulsory licensing, where a government allows someone else to produce a patented product without the consent of the patent owner, under certain conditions.
